Evolus Inc. August 2023 Investor Presentation

Evolus Inc. presented its August 2023 investor update covering the commercial performance of Jeuveau® and development progress of Evolysse™, an investigational dermal filler line. The presentation outlines market opportunities, product strategy, and clinical trial plans including a Phase II study for an extra-strength Jeuveau® formulation.